Clinical Trials

Intermittent Fasting, Pancreatic Neoplasms

NCT07528430 2026-04-14

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer

Not yet recruiting

450 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT07529626 2026-04-14

MIND-PANC

Not yet recruiting

320 enrolled

Pancreatic cancer, adult, Anxiety Disorders, Depression, Pancreatic Neoplasms, Disease Progression

NCT02872831 2026-04-13

Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle

Phase NA Withdrawn

Lymphadenopathy, Pancreatic Neoplasms, Cholangiocarcinoma

NCT03250078 2026-04-13

A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals

200 enrolled

Neoplasms, Pancreatic Neoplasms

NCT03403049 2026-04-13

Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

Phase 1 Completed

14 enrolled

Neoplasms, Pancreatic Neoplasms

NCT03937453 2026-04-13

PANDOME

800 enrolled

Diabetes Mellitus, Neoplasms, Pancreatic Neoplasms

NCT04406831 2026-04-13

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

200 enrolled

Neoplasms, Pancreatic Neoplasms

NCT06454383 2026-04-13

Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer

Phase 1 Recruiting

19 enrolled

Phase NA Not yet recruiting

Pancreatic Neoplasms

NCT07494994 2026-04-13

SURGIMEDIA

60 enrolled

Phase 2 Active not recruiting

Pancreatic Neoplasms

NCT05632328 2026-04-08

AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC

24 enrolled

Pancreatic Neoplasms

NCT06958328 2026-04-08

LAP100

Phase 3 Recruiting

356 enrolled

Phase NA Not yet recruiting

Pancreatic Neoplasms

NCT07516392 2026-04-08

PRE-PDAC

1,140 enrolled

Genetic Risk Score, Pancreatic Neoplasms, Genetic Predisposition to Disease

NCT04449406 2026-04-07

UroPanc

Active not recruiting

3,500 enrolled

Pancreatic Neoplasms

NCT05743049 2026-04-07

Collection of Circulating Biomarkers in Pancreatic Cancer

30 enrolled

Pancreatic Neoplasms

NCT06639724 2026-04-07

Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer

Phase 1 Recruiting

36 enrolled

Pancreatic Neoplasms

NCT04132505 2026-04-06

Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer

Phase 1 Completed

34 enrolled

Pancreatic Neoplasms

NCT07478185 2026-04-03

Prehab for Pancreatic Cancer Surgery

20 enrolled

Pancreatic cancer, adult, Pancreatic Neoplasms

NCT01102556 2026-04-02

PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease

1,000 enrolled

Phase 2 Active not recruiting

Pancreatic Neoplasms

NCT04820179 2026-04-02

Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer

30 enrolled

Pancreatic Neoplasms

NCT05617872 2026-04-02

Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound

Phase NA Completed

75 enrolled

Pancreatic Neoplasms

NCT01580241 2026-04-01

Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer

Active not recruiting

60 enrolled

Pancreatic Neoplasms

NCT05871164 2026-04-01

RAFPAN2

200 enrolled

Pancreatic Neoplasms

NCT06001268 2026-04-01

STRONG-PCS

80 enrolled

DermatologicGastrointestinal

Pancreatic Neoplasms

NCT06483555 2026-04-01

PANGEA

Phase 1/2 Recruiting

104 enrolled

Pancreatic Neoplasms, Neoplasms, Basal Cell

NCT06953193 2026-04-01

Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined Anesthesia

206 enrolled

Hypotension, Pancreatic Neoplasms, Postoperative Complications

NCT05380414 2026-03-31

Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients

750 enrolled

Pancreatic Neoplasms

NCT05438927 2026-03-31

Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer

Phase NA Completed

50 enrolled

Phase NA Active not recruiting

Pancreatic Neoplasms

NCT06050395 2026-03-31

The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response

40 enrolled

Pancreatic Neoplasms

NCT06630910 2026-03-31

whipple

Phase NA Completed

48 enrolled

Duodenal Neoplasms, Pancreatic Neoplasms

NCT07504471 2026-03-31

Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases

Phase 2 Recruiting

50 enrolled

Pancreatic Neoplasms

NCT03060720 2026-03-30

Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy

Active not recruiting

271 enrolled

Pancreatic Neoplasms

NCT05068752 2026-03-30

Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer

Phase 2 Completed

10 enrolled 15 charts

Neoplasm Metastasis, Pancreatic Neoplasms

NCT05837767 2026-03-30

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

BreastDermatologicGastrointestinalGenitourinarySarcomaThoracic

26 enrolled

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Sarcoma, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT05984602 2026-03-30

A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer

Phase 1 Active not recruiting

9 enrolled

Gastrointestinal Neoplasms, Pancreatic Neoplasms

NCT02676349 2026-03-27

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

Phase 2 Completed

130 enrolled